Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Allogene Therapeutics (ALLO) Interest Expenses (2024 - 2025)

Historic Interest Expenses for Allogene Therapeutics (ALLO) over the last 2 years, with Q3 2025 value amounting to $344000.0.

  • Allogene Therapeutics' Interest Expenses rose 24400.0% to $344000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $843000.0, marking a year-over-year increase of 74300.0%. This contributed to the annual value of $181000.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Allogene Therapeutics reported Interest Expenses of $344000.0 as of Q3 2025, which was up 24400.0% from $268000.0 recorded in Q2 2025.
  • Over the past 5 years, Allogene Therapeutics' Interest Expenses peaked at $344000.0 during Q3 2025, and registered a low of $81000.0 during Q4 2024.